EBITDA Margin % is calculated as EBITDA divided by its Revenue. Welcia Holdings Co's EBITDA for the
three
months ended in Aug. 2025 was $199 Mil. Welcia Holdings Co's Revenue for the
three
months ended in Aug. 2025 was $2,335 Mil. Therefore, Welcia Holdings Co's EBITDA margin for the quarter that ended in Aug. 2025 was 8.53%.
Welcia Holdings Co (OTCPK:WLCGF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Welcia Holdings Co EBITDA Margin % Related Terms
Welcia Holdings Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Welcia Holdings Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welcia Holdings Co EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Welcia Holdings Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welcia Holdings Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Welcia Holdings Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Welcia Holdings Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welcia Holdings Co (WLCGF) has a EBITDA Margin % of 8.53% as of Aug. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Welcia Holdings Co and its competitors. This is 49% above median its historical median of 5.74. Over the past decade, Welcia Holdings Co's EBITDA Margin % has ranged from 4.15 to 6.18.
Is Welcia Holdings Co's EBITDA Margin % too high?
Welcia Holdings Co's current EBITDA Margin % of 8.53% is 49% above median its 10-year median of 5.74. Over the past 10 years, this metric has ranged from a low of 4.15 to a high of 6.18. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Welcia Holdings Co's value of 8.53% is 16.5% below this industry median. Overall, Welcia Holdings Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Welcia Holdings Co's EBITDA Margin % compare to competitors?
Welcia Holdings Co's EBITDA Margin % of 8.53% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. Welcia Holdings Co's value of 8.53% is 16.5% below this benchmark. Historically, Welcia Holdings Co's own EBITDA Margin % has ranged from 4.15 to 6.18 over the past decade. While the company's 10-year median is 5.74 vs. the industry median of 10.21, Welcia Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Welcia Holdings Co's current EBITDA Margin % of 8.53% is 16.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Welcia Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welcia Holdings Co's current EBITDA Margin % is 8.53%, which is 49% above median its own 10-year median of 5.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcia Holdings Co stock overvalued right now?
Welcia Holdings Co (WLCGF) has a current EBITDA Margin % of 8.53%. The stock's GF Value™ is $14.20, compared to a current price of $16.41 — trading 15.6% above its estimated fair value. The current EBITDA Margin % is 8.53%, which is 49% above median its 10-year median of 5.74 and 16.5% below the Healthcare Providers & Services industry median of 10.21. Welcia Holdings Co's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Welcia Holdings Co (WLCGF), the current EBITDA Margin % is 8.53% as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Welcia Holdings Co (WLCGF) Overvalued in 2026?
Based on GuruFocus' analysis, Welcia Holdings Co stock appears to be overvalued.
The current stock price of $16.41 is trading 15.6% above its estimated GF Value™ of $14.20.
Key valuation signals for WLCGF:
EBITDA Margin %: 8.53% (49% above median its 10-year median of 5.74)
GF Value™: $14.20 vs. price of $16.41 (15.6% above fair value)
Industry Position: 16.5% below the Healthcare Providers & Services median
No single metric tells the full story. See the WLCGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Welcia Holdings Co Ltd operates drug retail stores that sell pharmaceuticals, health and beauty products, baby supplies, health supplements, sanitation items, groceries, and personal-care products. The company generates the bulk of its revenue through sales of over-the-counter drugs and food products. Welcia is involved in pharmaceutical dispensing, blood testing, and earthquake reconstruction assistance. The highest concentration of sales remains in the Kanto region of Japan. Welcia also provides nursing services through its long-term care enterprise.
18GF Score
Get the complete analysis for WLCGF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WLCGF has been successfully added to your 
